| 1 |
34494892 | Implications of the NADase CD38 in COVID pathophysiology. | 2022 Jan 1 |
2 |
| 2 |
34896700 | The calcium signaling enzyme CD38 - a paradigm for membrane topology defining distinct protein functions. | 2022 Jan |
1 |
| 3 |
35138178 | The CD38 glycohydrolase and the NAD sink: implications for pathological conditions. | 2022 Mar 1 |
6 |
| 4 |
35203360 | Maintenance of NAD+ Homeostasis in Skeletal Muscle during Aging and Exercise. | 2022 Feb 17 |
2 |
| 5 |
35294260 | Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. | 2022 Mar 16 |
1 |
| 6 |
35386537 | Conceptual Framework for SARS-CoV-2-Related Lymphopenia. | 2022 |
2 |
| 7 |
35420434 | Profiling Glutathionylome in CD38-Mediated Epithelial-Mesenchymal Transition. | 2022 May 6 |
2 |
| 8 |
35429545 | Elevated CD38 expression characterizes impaired CD8+ T cell immune response in metastatic pleural effusions. | 2022 May |
2 |
| 9 |
35457121 | CD38-Cyclic ADP-Ribose Signal System in Physiology, Biochemistry, and Pathophysiology. | 2022 Apr 13 |
1 |
| 10 |
35602958 | Functional assessment of the cell-autonomous role of NADase CD38 in regulating CD8+ TÂ cell exhaustion. | 2022 May 20 |
2 |
| 11 |
33303985 | Author Correction: Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. | 2021 Jan |
1 |
| 12 |
33353981 | NAD+ metabolism and its roles in cellular processes during ageing. | 2021 Feb |
2 |
| 13 |
33385109 | Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis. | 2021 Jan 22 |
4 |
| 14 |
33461448 | NAD Precursors, Mitochondria Targeting Compounds and ADP-Ribosylation Inhibitors in Treatment of Inflammatory Diseases and Cancer. | 2021 |
3 |
| 15 |
33485900 | NAD+ and cardiovascular diseases. | 2021 Apr |
1 |
| 16 |
33930374 | CD38 and MGluR1 as possible signaling molecules involved in epileptogenesis: A potential role for NAD+ homeostasis. | 2021 Aug 15 |
2 |
| 17 |
33936090 | The Key Role of NAD+ in Anti-Tumor Immune Response: An Update. | 2021 |
1 |
| 18 |
34112762 | CD38 deficiency alleviates Ang II-induced vascular remodeling by inhibiting small extracellular vesicle-mediated vascular smooth muscle cell senescence in mice. | 2021 Jun 11 |
2 |
| 19 |
34142751 | The new insight into extracellular NAD+ degradation-the contribution of CD38 and CD73 in calcific aortic valve disease. | 2021 Jun 18 |
3 |
| 20 |
34302821 | Risks and rewards of targeting NAD+ homeostasis in the brain. | 2021 Sep |
1 |
| 21 |
34509469 | The balance between NAD+ biosynthesis and consumption in ageing. | 2021 Oct |
3 |
| 22 |
34525347 | Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy. | 2021 Dec 2 |
1 |
| 23 |
34559251 | Aryl hydrocarbon receptor (AHR) functions in infectious and sterile inflammation and NAD+-dependent metabolic adaptation. | 2021 Nov |
1 |
| 24 |
34666225 | Profound inhibition of CD73-dependent formation of anti-inflammatory adenosine in B cells of SLE patients. | 2021 Nov |
1 |
| 25 |
34777396 | Development of Exhausted Memory Monocytes and Underlying Mechanisms. | 2021 |
1 |
| 26 |
34835990 | Role of CD38 in Adipose Tissue: Tuning Coenzyme Availability? | 2021 Oct 23 |
3 |
| 27 |
34871367 | NAD+-consuming enzymes in immune defense against viral infection. | 2021 Dec 10 |
1 |
| 28 |
31952784 | Targeting NAD+ Synthesis to Potentiate CD38-Based Immunotherapy of Multiple Myeloma. | 2020 Jan |
3 |
| 29 |
31995750 | Cross-talk between CD38 and TTP Is Essential for Resolution of Inflammation during Microbial Sepsis. | 2020 Jan 28 |
1 |
| 30 |
32013131 | Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs). | 2020 Jan 29 |
1 |
| 31 |
32046066 | One Single Nucleotide Polymorphism of the TRPM2 Channel Gene Identified as a Risk Factor in Bipolar Disorder Associates with Autism Spectrum Disorder in a Japanese Population. | 2020 Feb 7 |
1 |
| 32 |
32061543 | CD38: Modulating Histone Methyltransferase EZH2 Activity in SLE. | 2020 Mar |
1 |
| 33 |
32169417 | Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD). | 2020 May |
2 |
| 34 |
32231086 | A Novel NAD-RNA Decapping Pathway Discovered by Synthetic Light-Up NAD-RNAs. | 2020 Mar 28 |
1 |
| 35 |
32319590 | CD38 is involved in cell energy metabolism via activating the PI3K/AKT/mTOR signaling pathway in cervical cancer cells. | 2020 Jul |
6 |
| 36 |
32480246 | Role of CD38/cADPR signaling in obstructive pulmonary diseases. | 2020 Apr |
1 |
| 37 |
32535108 | Aryl hydrocarbon receptor (AHR) functions: Balancing opposing processes including inflammatory reactions. | 2020 Aug |
1 |
| 38 |
32594513 | Implications of NAD+ boosters in translational medicine. | 2020 Oct |
2 |
| 39 |
32709019 | CD38: T Cell Immuno-Metabolic Modulator. | 2020 Jul 17 |
6 |
| 40 |
32717131 | Interleukin-8 drives CD38 to form NAADP from NADP+ and NAAD in the endolysosomes to mobilize Ca2+ and effect cell migration. | 2020 Sep |
1 |
| 41 |
32935380 | Re-equilibration of imbalanced NAD metabolism ameliorates the impact of telomere dysfunction. | 2020 Nov 2 |
1 |
| 42 |
32941246 | The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis. | 2020 Nov |
5 |
| 43 |
33182523 | Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders. | 2020 Nov 9 |
2 |
| 44 |
33199923 | CD38-expressing macrophages drive age-related NAD+ decline. | 2020 Nov |
1 |
| 45 |
33199924 | Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. | 2020 Nov |
3 |
| 46 |
33199925 | CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels. | 2020 Nov |
4 |
| 47 |
33329591 | CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity. | 2020 |
3 |
| 48 |
29295624 | NAD+ Deficiency Is a Common Central Pathological Factor of a Number of Diseases and Aging: Mechanisms and Therapeutic Implications. | 2019 Feb 20 |
1 |
| 49 |
29550257 | Canonical and non-canonical adenosinergic pathways. | 2019 Jan |
1 |
| 50 |
29634344 | Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes. | 2019 Jan 10 |
1 |